Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Cash from Operations (2016 - 2026)

Tenax Therapeutics' Cash from Operations history spans 8 years, with the latest figure at 1282071.0 for Q4 2017.

  • On a quarterly basis, Cash from Operations rose 58.71% to 1282071.0 in Q4 2017 year-over-year; TTM through Dec 2017 was 12140517.0, a 23.51% increase, with the full-year FY2025 number at 35800000.0, down 141.89% from a year prior.
  • Cash from Operations hit 1282071.0 in Q4 2017 for Tenax Therapeutics, down from 1225932.0 in the prior quarter.
  • Over the last five years, Cash from Operations for TENX hit a ceiling of 739010.0 in Q1 2013 and a floor of 8950610.0 in Q4 2015.
  • Historically, Cash from Operations has averaged 3159834.28 across 5 years, with a median of 3042493.5 in 2014.
  • Biggest five-year swings in Cash from Operations: tumbled 266.07% in 2014 and later soared 71.36% in 2017.
  • Tracing TENX's Cash from Operations over 5 years: stood at 2013226.0 in 2013, then increased by 1.53% to 1982377.0 in 2014, then crashed by 351.51% to 8950610.0 in 2015, then surged by 65.31% to 3105069.0 in 2016, then soared by 58.71% to 1282071.0 in 2017.
  • Business Quant data shows Cash from Operations for TENX at 1282071.0 in Q4 2017, 1225932.0 in Q3 2017, and 5595218.0 in Q2 2017.